Nanostructured Lipid Carriers to Deliver HIV p24 Antigen and CpG Immunostimulant in Mice and Non-Human Primates Immunogenicity Studies
Bayon E., Bosquet N., Gonon A., Gosse L., Le Grand R., Marche P.N., Morlieras J., Navarro F.P., CEA-LETI, FR
Fighting HIV pandemic is one of today’s major health priorities and vaccination remains the most challenging issue against HIV propagation. Until now, the best vaccine candidate showed only 30% protection in RV144 clinical trial [1]. [...]